Ortho Clinical increases revolver to $500 million, extends to 2026

By Wendy Van Sickle

Columbus, Ohio, Feb. 9 – Ortho Clinical Diagnostics SA said some of its subsidiaries amended their June 30, 2014 credit agreement to increase the revolver size by $150 million to $500 million and extend the maturity date to Feb. 26, 2026, according to a news release.

The issuer is a Raritan, N.J.-based in vitro diagnostics company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.